Plain-English translation of NCT07553572 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing an artificial intelligence smartphone application called ASSIST that's designed to help cancer patients manage symptoms and side effects during treatment. The app provides personalized support tailored to your needs while you receive standard cancer care from your medical team. Researchers want to see if the app is easy to use and helpful for patients going through cancer treatment.
Many cancer patients struggle with managing side effects and symptoms while undergoing treatment, and they often don't have easy access to support between doctor visits. This trial exists to see if a smartphone app can fill that gap by giving patients quick, personalized help whenever they need it.
You likely qualify if…
You likely don't qualify if…
If you're selected for the study, you'll be randomly assigned to either use the ASSIST smartphone app or receive your usual cancer care without the app. If you're in the app group, you'll use ASSIST on your smartphone for 12 weeks while continuing your regular cancer treatment and doctor visits. All participants will complete surveys during the study so researchers can understand how helpful the app was and how easy it was to use.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States